Interestingly, IGHD patients also had low insulin levels and relatively low IR, though their -cell function was reduced and their frequency of impaired glucose tolerance was increased [124, 125]
Representative image (AI-generated) NEW DELHI: The booming demand for weight-loss drugs has now caught the attention of Indias drug regulator, with a series of raids across the country revealing just how easily these prescription medicines are finding their way to consumers.In recent weeks, inspections at 49 locationsranging from online pharmacy warehouses and wholesalers to retail chemists and wellness clinicshave uncovered gaps in how GLP-1 drugs are being sold and promoted
Treatment is based on symptomatic relief and prevention of the diseases clinical manifestation of mediator release
Kovacs-Nolan J 1 , Rupa P , Matsui T , Tanaka M , Konishi T , Sauchi Y , Sato K , Ono S , Mine Y